Table 3 Knowledge regarding cognitive dysfunction in Parkinson’s disease and cognitive rehabilitation
Knowledge | Known/correct n (%) | |
|---|---|---|
Physicians | Nurses | |
K1. Cognitive dysfunction is one of the common non-motor symptoms of PD, including mild cognitive impairment (MCI) and Parkinson’s disease dementia (PDD). | 23 (10.27) | 17 (8.13) |
K2. MCI is an intermediate state between normal cognitive function and PDD. | 105 (46.88) | 139 (66.51) |
K3. The risk factors for the development of dementia in PD patients. | 107 (47.77) | 72 (34.45) |
K4. The medications that should be discontinued in PD patients with Cognitive dysfunction. | 40 (17.86) | 25 (11.96) |
K5. MCI in PD can appear in the early stage of the disease and may even precede the onset of motor impairment. | 193 (86.16) | 165 (78.95) |
K6. The Montreal Cognitive Assessment (MoCA), the Parkinson′s Disease Cognitive Rating Scale (PD-CRS), and the Mattis Dementia Rating Scale-2 (MDRS-2) are the three scales currently recommended for evaluating overall cognitive function in PD with better validity and reliability. | 72 (32.14) | 27 (12.92) |
K7. The rehabilitation treatments for PD have proven effective. | 103 (45.98) | 50 (23.92) |
K8. How to carry out cognitive training for patients. | 80 (35.71) | 46 (22.01) |
K9. Aerobic exercise may be effective in improving executive function in PD patients, and appropriate aerobic exercise, such as horizontal exercise bicycles, is recommended for PD patients with MCI. | 92 (41.07) | 50 (23.92) |
K10. Transcranial direct current stimulation (tDCS) treatment may be considered for PD patients with MCI. | 88 (39.29) | 45 (21.53) |
K11. The dietary precautions for PD patients. | 103 (45.98) | 65 (31.10) |